These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8289963

  • 1. [Treatment of multiple sclerosis using recombinant interferon-beta].
    Polman CH, Barkhof F, van Loenen AC, Lucas CJ, Koetsier JC.
    Ned Tijdschr Geneeskd; 1994 Jan 01; 138(1):7-10. PubMed ID: 8289963
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug 01; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract] [Full Text] [Related]

  • 4. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, Fischer JS, Goodkin DE, Granger CV, Simon JH, Alam JJ, Bartoszak DM, Bourdette DN, Braiman J, Brownscheidle CM, Coats ME, Cohan SL, Dougherty DS, Kinkel RP, Mass MK, Munschauer FE, Priore RL, Pullicino PM, Scherokman BJ, Whitham RH.
    Ann Neurol; 1996 Mar 01; 39(3):285-94. PubMed ID: 8602746
    [Abstract] [Full Text] [Related]

  • 5. [The role of interferon beta in the treatment of multiple sclerosis].
    Seeldrayers P.
    Rev Med Brux; 1999 Sep 01; 20(4):A264-7. PubMed ID: 10523902
    [Abstract] [Full Text] [Related]

  • 6. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland].
    Huber S, Spycher M, Lechner-Scott J, Bellaiche Y, Steck AJ, Kappos L.
    Schweiz Med Wochenschr; 1996 Aug 31; 126(35):1475-81. PubMed ID: 8927950
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Magnetic resonance imaging as an outcome measure in the treatment of multiple sclerosis: results of the interferon beta trial.
    Koopmans RA, Paty DW.
    Mult Scler; 1995 Aug 31; 1 Suppl 1():S22-3. PubMed ID: 9345393
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Clinical testing of the treatment effect of interferon-beta Ia and Ib in multiple sclerosis].
    de Haan RJ, Polman CH.
    Ned Tijdschr Geneeskd; 1996 Nov 02; 140(44):2168-71. PubMed ID: 8984352
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early treatment.
    Comi G.
    Neurol Sci; 2006 Mar 02; 27 Suppl 1():S8-12. PubMed ID: 16708191
    [Abstract] [Full Text] [Related]

  • 13. Interferon beta-1A for relapsing multiple sclerosis.
    Med Lett Drugs Ther; 1996 Jul 19; 38(979):63-4. PubMed ID: 8692073
    [No Abstract] [Full Text] [Related]

  • 14. Increases in soluble VCAM-1 correlate with a decrease in MRI lesions in multiple sclerosis treated with interferon beta-1b.
    Calabresi PA, Tranquill LR, Dambrosia JM, Stone LA, Maloni H, Bash CN, Frank JA, McFarland HF.
    Ann Neurol; 1997 May 19; 41(5):669-74. PubMed ID: 9153530
    [Abstract] [Full Text] [Related]

  • 15. Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a.
    Barkhof F, Rocca M, Francis G, Van Waesberghe JH, Uitdehaag BM, Hommes OR, Hartung HP, Durelli L, Edan G, Fernández O, Seeldrayers P, Sørensen P, Margrie S, Rovaris M, Comi G, Filippi M, Early Treatment of Multiple Sclerosis Study Group.
    Ann Neurol; 2003 Jun 19; 53(6):718-24. PubMed ID: 12783417
    [Abstract] [Full Text] [Related]

  • 16. Does interferon beta cause initial exacerbation of multiple sclerosis?
    Rudge P, Miller D, Crimlisk H, Thorpe J.
    Lancet; 1995 Mar 04; 345(8949):580. PubMed ID: 7776786
    [No Abstract] [Full Text] [Related]

  • 17. New treatments for multiple sclerosis.
    Hutchinson M.
    Ir Med J; 1996 Mar 04; 89(2):44. PubMed ID: 8682623
    [No Abstract] [Full Text] [Related]

  • 18. Interferon beta-1b in secondary progressive multiple sclerosis--outline of the clinical trial.
    Polman CH, Dahlke F, Thompson AJ, Ghazi M, Kappos L, Miltenburger C, Pozilli C.
    Mult Scler; 1995 Mar 04; 1 Suppl 1():S51-4. PubMed ID: 9345400
    [Abstract] [Full Text] [Related]

  • 19. A double blind, placebo-controlled, phase II, add-on study of cyclophosphamide (CTX) for 24 months in patients affected by multiple sclerosis on a background therapy with interferon-beta study denomination: CYCLIN.
    Patti F, Amato MP, Filippi M, Gallo P, Trojano M, Comi GC.
    J Neurol Sci; 2004 Aug 15; 223(1):69-71. PubMed ID: 15261564
    [Abstract] [Full Text] [Related]

  • 20. Biogen wins Euro MS approval, but loses patents.
    Brower V.
    Nat Biotechnol; 1997 May 15; 15(5):410. PubMed ID: 9131611
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.